Articles related to KIDNEY DISEASE

SGLT-2 inhibitors have emerged as a cornerstone in managing HFrEF and CKD, demonstrating substantial reductions in cardiovascular and renal adverse outcomes. This class of medications is reshaping the therapeutic approach in patients with these comorbid conditions, providing a dual benefit that was once considered challenging to achieve.

In a recent study assessing chronic insomnia treatments in hemodialysis patients, no significant difference was observed between CBT-I, trazodone, and placebo in improving Insomnia Severity Index scores. This highlights a critical need for alternative therapeutic approaches in this unique patient population.

Recent studies reveal that adding ezetimibe to lower-intensity statin therapy is as effective as high-intensity statin therapy alone in preventing major cardiovascular events, offering a new approach to lipid management in patients intolerant to high-intensity statins.

In the delicate dance of AI and healthcare, a sobering revelation surfaces—predictive models, designed to enhance accuracy in ICU predictions, may inadvertently compromise their own efficacy.

A recent case of a 38-year-old man with end-stage renal disease highlighted the rare but significant complication of quadriceps tendon rupture, often associated with chronic kidney disease and secondary hyperparathyroidism.

A recent study from Fox Chase Cancer Center has revealed that as many as 23% of cystic renal masses may carry high-grade, or aggressive, disease. This finding challenges the prevailing assumption of their low-risk nature and underscores the need for more discerning diagnostic and treatment strategies.